Registry for Advanced Sarcodiosis (REAS)

University of Cincinnati

Status: Unknown

Conditions: Sarcoidosis

Treatments: Other: observation

Study type: Observational

Funder types: Other

Identifiers

NCT03769987

REAS

Details and patient eligibility

About

Registry with evaluation and genetic information of patients with advanced sarcoidosis and matched sarcoidosis

Enrollment: 800 estimated patients

Sex: All

Ages: 15 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22
• Age ≥ 18 years.
• Life expectancy of at least 2 years.
• Pulmonary function tests (spirometry) within one month of entry or willing to under pulmonary function testing on the day of study enrollment
• Sarcoidosis as characterized as either advanced or non-advanced (see protocol for definition of advanced disease)
• Subjects must be able to understand and be willing to sign the written informed consent form. A signed informed consent form must be appropriately obtained prior to the conduct of any trial-specific procedure.

Exclusion criteria

• Subjects with a medical disorder, condition, or history of such that would impair the subject's ability to participate or complete this study in the opinion of the investigator
• Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
• Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation.